enVVeno Medical (NVNO) Preferred Stock Liabilities (2017)
enVVeno Medical (NVNO) posted quarterly Preferred Stock Liabilities of $3.9 million for Q4 2017.
enVVeno Medical (NVNO) Preferred Stock Liabilities (2017) Analysis & Trends
enVVeno Medical's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $3.9 million for Q4 2017.
- In Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $3.9 million; the TTM figure through Dec 2017 stood at $3.9 million (changed N/A YoY), while the FY2017 annual figure was $3.9 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q4 2017 stood at $3.9 million.
- The five-year high for Preferred Stock Liabilities was $3.9 million in Q4 2017, with the low at $3.9 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | enVVeno Medical | 7.05 Mn | 7.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 3.94 Mn |